Solasto Corporation

Tokyo Stock Exchange 6197.T

Solasto Corporation Capital Expenditure for the year ending March 31, 2024: USD -10.41 M

Solasto Corporation Capital Expenditure is USD -10.41 M for the year ending March 31, 2024, a -4.48% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Solasto Corporation Capital Expenditure for the year ending March 31, 2023 was USD -9.97 M, a -52.02% change year over year.
Solasto Corporation Capital Expenditure for the year ending March 31, 2022 was USD -6.56 M, a 23.58% change year over year.
Solasto Corporation Capital Expenditure for the year ending March 31, 2021 was USD -8.58 M, a 28.82% change year over year.
Solasto Corporation Capital Expenditure for the year ending March 31, 2020 was USD -12.05 M, a -79.60% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Tokyo Stock Exchange: 6197.T

Solasto Corporation

CEO	Mr. Toru Noda
IPO Date	June 29, 2016
Location	Japan
Headquarters	1-7-18 Konan
Employees	33,884
Sector	Industrials
Industries Professional Services Hospitals & Clinics

Description

Solasto Corporation provides medical outsourcing services primarily to medical institutions in Japan. The company's medical outsourcing services include contracted services of medical clerical work. It also offers elderly care services, such as day service, home help, facility-based service, etc.; and childcare services, as well as engages in the education business. The company was formerly known as N.I.C Corporation. Solasto Corporation was founded in 1965 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years